title: Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant.
authors.affiliation: Department I of Internal Medicine, University Hospital Cologne , Cologne , Germany.
authors.forename: Bastian
authors.initials: B
authors.lastname: von Tresckow
authors.forename: Horst
authors.initials: H
authors.lastname: Müller
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Eichenauer
authors.forename: Jan P
authors.initials: JP
authors.lastname: Glossmann
authors.forename: Andreas
authors.initials: A
authors.lastname: Josting
authors.forename: Boris
authors.initials: B
authors.lastname: Böll
authors.forename: Beate
authors.initials: B
authors.lastname: Klimm
authors.forename: Stephanie
authors.initials: S
authors.lastname: Sasse
authors.forename: Michael
authors.initials: M
authors.lastname: Fuchs
authors.forename: Peter
authors.initials: P
authors.lastname: Borchmann
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
mesh_terms: D018450:Disease Progression; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local; D063868:Patient Outcome Assessment; D012307:Risk Factors; D014182:Transplantation, Autologous